Chronic vascular effects of oat phenolic acids and avenanthramides in pre- or stage 1 hypertensive adults

Wholegrain consumption is linked to a lower risk of cardiovascular disease. Evidence from randomized controlled trials have established that the consumption of wholegrain oats lowers blood cholesterol, via a mechanism partly mediated by β-glucan soluble fiber. However, oats contain an arrayof phenolic acids, including ferulic acid and also structurally related avenanthramides, which mayalso contribute to the cardiovascular health benefits of oat intake. We investigated whether 4 weeks, daily consumption of oat phenolics leads to improvement in markers of CVD risk men and women.In a 3 arm crossover single-blind, placebo-controlled trial, 28 volunteers consumed either: 1) oatmeal/oatcake intervention (-containing 48.9mg of phenolic acids and 19.2mg of avenanthramides); 2) oatbran concentrate+rice porridge/wheat cracker intervention (-containing 38.4mg of phenolic acidsand 0.5mg of avenanthramides) or 3) rice porridge/wheat cracker intervention (containing 13.8mg of phenolic acids). All treatments were matched in soluble fiber (4.8g) and energy (500kcal). The primary endpoint was FMD and other cardiovascular endpoints were blood pressure, LDI, LDL/HDL cholesterol, platelets and endothelial cell-derived extracellular vesicles (EVs). All measures were taken at baseline and after three, 4 week long intervention periods and two washout periods.Our data indicates an increase by 1.09 %±0.41 %(Mean± SEM) in FMD response following high phenolic oat intake with a significant difference (P=0.007) between baseline and postintervention. Consumption of high phenolic oats also led to a significant improvement in 24-hour SBP, day time SBP and night time SBP (P<0.01, P<0.01 and P<0.05) and day time and night time DBP (p<0.05). There was also a significant decrease with total and LDL cholesterol after the consumption of moderate and high phenolic oat interventions (P